Testing Status of AZT + Rifabutin (AIDS Initiative) M950055
CASRN: AZTRIFABUTIN
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 72559-06-9 - Rifabutin
Organ Systems Toxicity
- 30 days Repro/Dev Gen Tox (28-Day) (Gavage)
(RDGT95003)
Completed
- NIH Number: 00-3948
Citation: NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Rifabutin Combinations (CASRNs 30516-87-1 and 72559-06-9) Administered by Gavage to Swiss (CD-1®) Mice - Male and Female Mice: Swiss CD-1
- Dose: 200 or 400 mg of AZT/kg/day and 80, 320, or 640 mg of rifabutin/kg/day.
- NIH Number: 00-3948